These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 20888837

  • 1. The possible involvement of dopamine D3 receptors in the regulation of gastric emptying in rats.
    Yoshikawa T, Yoshida N.
    Life Sci; 2010 Nov 20; 87(19-22):638-42. PubMed ID: 20888837
    [Abstract] [Full Text] [Related]

  • 2. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 20; 275(2):899-913. PubMed ID: 7473181
    [Abstract] [Full Text] [Related]

  • 3. Activation of dopamine D(3) receptors induces c-fos expression in primary cultures of rat striatal neurons.
    Morris BJ, Newman-Tancredi A, Audinot V, Simpson CS, Millan MJ.
    J Neurosci Res; 2000 Mar 15; 59(6):740-9. PubMed ID: 10700011
    [Abstract] [Full Text] [Related]

  • 4. The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying.
    Kashyap P, Micci MA, Pasricha S, Pasricha PJ.
    Dig Dis Sci; 2009 Jan 15; 54(1):57-62. PubMed ID: 18600456
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
    Katz JL, Alling KL.
    Behav Pharmacol; 2000 Sep 15; 11(6):483-93. PubMed ID: 11103914
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ, Girardon S, Monneyron S, Dekeyne A.
    Neuropharmacology; 2000 Feb 14; 39(4):586-98. PubMed ID: 10728880
    [Abstract] [Full Text] [Related]

  • 7. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I, Sághy K.
    Behav Pharmacol; 2004 Jul 14; 15(4):253-62. PubMed ID: 15252275
    [Abstract] [Full Text] [Related]

  • 8. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ, Audinot V, Melon C, Newman-Tancredi A.
    Eur J Pharmacol; 1995 Jul 04; 280(2):225-9. PubMed ID: 7589191
    [Abstract] [Full Text] [Related]

  • 9. The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.
    Altamirano-Espinoza AH, González-Hernández A, Manrique-Maldonado G, Marichal-Cancino BA, Ruiz-Salinas I, Villalón CM.
    Br J Pharmacol; 2013 Nov 04; 170(5):1102-11. PubMed ID: 24032529
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.
    García-Sanz A, Badia A, Clos MV.
    Synapse; 2001 Apr 04; 40(1):65-73. PubMed ID: 11170223
    [Abstract] [Full Text] [Related]

  • 11. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
    Darmani NA, Zhao W, Ahmad B.
    J Neural Transm (Vienna); 1999 Apr 04; 106(11-12):1045-61. PubMed ID: 10651102
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo.
    Gobert A, Lejeune F, Rivet JM, Cistarelli L, Millan MJ.
    J Neurochem; 1996 May 04; 66(5):2209-12. PubMed ID: 8780056
    [Abstract] [Full Text] [Related]

  • 13. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ.
    J Pharmacol Exp Ther; 1998 Oct 04; 287(1):187-97. PubMed ID: 9765337
    [Abstract] [Full Text] [Related]

  • 14. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
    Brudzynski SM, Komadoski M, St Pierre J.
    Behav Brain Res; 2012 Jan 15; 226(2):511-8. PubMed ID: 22015714
    [Abstract] [Full Text] [Related]

  • 15. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ, Baker LE.
    Pharmacol Biochem Behav; 1999 Oct 15; 64(2):373-8. PubMed ID: 10515316
    [Abstract] [Full Text] [Related]

  • 16. Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors.
    Bristow LJ, Cook GP, Patel S, Curtis N, Mawer I, Kulagowski JJ.
    Neuropharmacology; 1998 Jun 15; 37(6):793-802. PubMed ID: 9707293
    [Abstract] [Full Text] [Related]

  • 17. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
    Millan MJ, Peglion JL, Vian J, Rivet JM, Brocco M, Gobert A, Newman-Tancredi A, Dacquet C, Bervoets K, Girardon S.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):885-98. PubMed ID: 7473180
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
    Acquas E, Di Chiara G.
    Eur J Pharmacol; 1999 Oct 27; 383(2):121-7. PubMed ID: 10585525
    [Abstract] [Full Text] [Related]

  • 19. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
    Rivet JM, Audinot V, Gobert A, Peglion JL, Millan MJ.
    Eur J Pharmacol; 1994 Nov 24; 265(3):175-7. PubMed ID: 7875234
    [Abstract] [Full Text] [Related]

  • 20. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM, Welge JA, Levant B, Logue AD, Hayes S, Pritchard LM, Geracioti TD, Coolen LM, Berger SP.
    Neuropsychopharmacology; 2003 Aug 24; 28(8):1422-32. PubMed ID: 12700693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.